Skip to main content
. 2012 May 22;7(5):e37999. doi: 10.1371/journal.pone.0037999

Figure 3. Design and validation of 14-3-3ζ shRNA constructs.

Figure 3

A 14-3-3ζ specific shRNA sequences (1222 and 1854 bp) were cloned into pLentiLox3.7 vectors and B western blot analysis revealed that both constructs effectively reduced 14-3-3ζ protein levels in Neuro2A cells, the 1854 construct being most effective in vitro. C In situ hybridization confirmed effective knockdown of 14-3-3ζ in the CeA after infection with the 1854 shRNA expressing lentivirus. The top panels show 14-3-3ζ expression in the CeA after infection with the control or the 1854 shRNA expressing lentivirus. The bottom panels show GFP mRNA and therefore the infection site in adjacent sections. 14-3-3ζ mRNA is completely absent in the area that is infected with the 1854 shRNA expressing lentivirus.